Business Context and Reporting Period
Company: The Procter & Gamble Company (P&G)
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Three and six months ended December 31, 2025
Business Overview: P&G is a global leader in fast-moving consumer goods, operating across five reportable segments: Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care. The company sells products in approximately 180 countries.
Key Financial Metrics
| Metric (in millions, except per share) | Three Months Ended Dec 31, 2025 | Six Months Ended Dec 31, 2025 |
|---|---|---|
| Net Sales | $22,208 | $44,594 |
| Operating Income | $5,366 | $11,222 |
| Net Earnings Attributable to P&G | $4,319 | $9,070 |
| Diluted EPS | $1.78 | $3.73 |
| Operating Cash Flow | N/A | $10,380 |
| Adjusted Free Cash Flow | N/A | $8,701 |
| Cash and Cash Equivalents (Dec 31, 2025) | $10,825 | $10,825 |
| Total Debt (Current + Long-Term) | $36,639 | $36,639 |
Note: Total Debt calculated as Debt due within one year ($11,062) + Long-term debt ($25,577).
Material Changes vs. Prior Period
- Revenue: Net sales increased 1% ($22.2B) for the quarter and 2% ($44.6B) for the six-month period compared to the prior year. Growth was driven by favorable foreign exchange (+1%) and higher pricing (+1%), partially offset by a decline in unit volume (-1%).
- Profitability: Operating income decreased 7% for the quarter and 3% for the six-month period. Gross margin declined 120 basis points (quarter) and 90 basis points (six months) due to unfavorable product mix, higher restructuring costs, tariffs, and product investments.
- Earnings: Net earnings attributable to P&G decreased 7% for the quarter but increased 6% for the six-month period. The six-month increase was primarily due to a significant non-cash charge in the prior year related to the liquidation of operations in Argentina.
- Segment Performance:
- Beauty: Sales up 5% (quarter) and 6% (six months); driven by volume and pricing.
- Grooming: Sales up 2% (quarter) and 4% (six months); volume declined but pricing offset the decrease.
- Health Care: Sales up 5% (quarter) and 4% (six months); driven by mix and pricing.
- Fabric & Home Care: Sales up 1% (quarter) and 1% (six months); volume was flat to slightly down.
- Baby, Feminine & Family Care: Sales down 3% (quarter) and 1% (six months); driven by volume declines.
Guidance, Outlook, and Risks
- Restructuring Program: In June 2025, P&G announced a portfolio and productivity plan expecting to incur $1.5 to $2.0 billion in before-tax restructuring costs over two years. This includes a reduction of up to 7,000 non-manufacturing overhead personnel by the end of fiscal 2027. Costs incurred to date for the six months ended Dec 31, 2025, were $584 million.
- Core EPS: Management highlights Core EPS (excluding incremental restructuring) as a key metric. Core EPS increased 2% to $3.87 for the six months ended Dec 31, 2025, compared to a 7% increase in GAAP diluted EPS.
- Share Repurchases: The company reaffirmed an expectation to reduce outstanding shares through direct repurchases of approximately $5 billion in fiscal year 2026. During the quarter, the company repurchased 15.5 million shares.
- Risks and Contingencies:
- Foreign Exchange: Significant exposure to currency fluctuations, particularly devaluation of foreign currencies against the U.S. dollar.
- Commodities and Tariffs: Volatility in oil-derived materials and pulp, along with higher tariff costs, impacted margins.
- Geopolitical: Exposure to global economic volatility, including the war in Russia and Ukraine (Russia accounted for 1% of sales/assets).
- Impairment Risk: The Gillette indefinite-lived intangible asset ($12.8B carrying value) remains sensitive to changes in growth rates, discount rates, and royalty rates, though fair value currently exceeds carrying value by >10%.
Investor Verification Checklist
- Restructuring Execution: Verify the pace of the $1.5–$2.0 billion restructuring plan and the associated headcount reductions (up to 7,000 non-manufacturing roles).
- Margin Recovery: Monitor gross margin trends to assess if productivity savings and pricing actions can offset tariff costs and unfavorable mix.
- Volume Trends: Confirm if unit volume declines in Baby, Feminine & Family Care and Grooming segments stabilize or reverse.
- Foreign Exchange Impact: Track the impact of currency fluctuations on reported sales and earnings, given the company's significant international exposure.
- Debt Management: Review the company's ability to manage its debt load ($36.6B total) amidst potential interest rate changes and the planned $5B share repurchase program.